
Sign up to save your podcasts
Or


Katie and Matt discuss tariffs, skeptical questions, nondelegation, major questions, reimbursement, the Metsera deal, amylin targeting, Sam Bankman-Fried’s appeal, alleged fraud at First Brands, factoring due diligence, the blockchain and short memories in the credit market.
See omnystudio.com/listener for privacy information.
By Bloomberg4.8
379379 ratings
Katie and Matt discuss tariffs, skeptical questions, nondelegation, major questions, reimbursement, the Metsera deal, amylin targeting, Sam Bankman-Fried’s appeal, alleged fraud at First Brands, factoring due diligence, the blockchain and short memories in the credit market.
See omnystudio.com/listener for privacy information.

971 Listeners

407 Listeners

1,174 Listeners

2,169 Listeners

1,992 Listeners

437 Listeners

354 Listeners

2,453 Listeners

948 Listeners

970 Listeners

797 Listeners

195 Listeners

290 Listeners

205 Listeners

30 Listeners

443 Listeners

352 Listeners

4 Listeners

154 Listeners

58 Listeners

233 Listeners

228 Listeners

70 Listeners

88 Listeners

81 Listeners

87 Listeners

195 Listeners

21 Listeners

12 Listeners

8 Listeners

2 Listeners

123 Listeners